drugset

drugset / Trial / NCT01657890

Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects

NCT01657890 ↗

Phase 1 Completed 28 enrolled Astellas Pharma Global Development, Inc. Basilea Pharmaceutica International Ltd · collab

Non-randomizedParallel-groupOpen-label

Summary

The purpose of this study is to evaluate the pharmacokinetics of isavuconazole in healthy non-elderly and elderly male and female subjects.

Timeline

Start: 2012-06
Primary completion: 2013-01
Completion: 2013-01

Publications

Desai AV, Han D, Kowalski DL, Lademacher C, Pearlman H, Yamazaki T. No Dose Adjustment for Isavuconazole Based on Age or Sex. Antimicrob Agents Chemother. 2019 May 24;63(6):e02629-18. doi: 10.1128/AAC.02629-18. Print 2019 Jun.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Isavuconazole	Small molecule	200 mg	Oral

Indications

No indication recorded.